| Dr David Todd Fleischmann, MD | |
|
702 N Blackhawk Ave, Madison, WI 53705-3357 | |
| (608) 233-3037 | |
| Not Available |
| Full Name | Dr David Todd Fleischmann |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 702 N Blackhawk Ave, Madison, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811125487 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 6211920 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Todd Fleischmann, MD 4603 Sunburst Dr, Deforest, WI 53532-2455 Ph: (757) 289-2698 | Dr David Todd Fleischmann, MD 702 N Blackhawk Ave, Madison, WI 53705-3357 Ph: (608) 233-3037 |
News Archive
A parent's incarceration has immediate, devastating effects on a family. Now, Virginia Tech and University of Toronto researchers say there may be a longer term risk: Men who as children experienced a family member's incarceration are approximately twice as likely to have a heart attack in later adulthood in comparison with men who were not exposed to such a childhood trauma.
The ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has thrown much of the world into disarray, with over 4 million people reported infected and well over 282,000 deaths. A new study published on the preprint server bioRxiv in May 2020 suggests that the long-term impact of the virus could include activation of dormant bacterial infections like tuberculosis (TB).
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.
Cynosure, Inc., a developer and manufacturer of a broad array of light-based aesthetic treatment systems, and its largest shareholder, El.En. S.p.A., today filed a patent infringement lawsuit against CoolTouch Inc. in U.S. District Court for the District of Massachusetts.
Researchers in genomic health disparities from the University of Miami Miller School of Medicine and the Stanford University School of Medicine have teamed up to hold the second annual "Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine."
› Verified 1 days ago
Richard Lee Owens, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1920 Monroe St, Madison, WI 53711 Phone: 608-251-6060 Fax: 608-251-3930 | |
Dr. Adam Haskins Page, MD General Practice Medicare: Medicare Enrolled Practice Location: Uw Hospitals & Clinics 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6400 | |
Dr. Amin Afrazi, MD,PH.D General Practice Medicare: Medicare Enrolled Practice Location: Uw Hospital And Clinics, 600 Highland Ave, H4/831, Madison, WI 53792 Phone: 608-263-1377 | |
Jamaal Tarpeh, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 749 University Row Ste 200, Madison, WI 53705 Phone: 608-263-6400 | |
Graham Campbell, MD General Practice Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-623-6400 | |
Dr. Robin Louise Chene, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 530 W Lakeside St, Madison, WI 53715 Phone: 608-258-9721 | |
Dr. Kathy J Russeth, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 345 W Washington Ave Ste 307, Madison, WI 53703 Phone: 414-395-5435 |